TIF1β激活HSC中的白血病转录程序,并促进BCR::ABL1诱导的髓性白血病
Mariko Morii1, Sho Kubota1, Mihoko Iimori1
1Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Leukemia
|May 11, 2024
概括
染色质调节器TIF1β驱动了BCR::ABL1小鼠的髓性白血病进展. 删除TIF1β可以抑制白血病并改善存活率,这表明TIF1β是治疗点.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- TIF1β (TRIM28) 是一种染色素调节器,影响正常和恶性细胞中的基因转录.
- 在慢性和急性髓性白血病患者中观察到TIF1β表达升高.
研究的目的:
- 研究TIF1β在BCR::ABL1诱导的髓性白血病中的作用.
- 探索TIF1β作为白血病的潜在治疗点.
主要方法:
- 生成一个BCR::ABL1条件敲入鼠标模型.
- 在白血病模型中删除Tif1β基因.
- 基因表达的分析,染色质的可访问性和药物敏感性.
主要成果:
- 在小鼠中,Tif1β的缺失抑制了髓性白血病的进展,并增加了生存率.
- Tif1β 缺失使白血病细胞对达沙替尼敏感.
- TIF1β直接结合并激活像FOSL1这样的增殖基因,导致白血病.
结论:
- TIF1β在驱动BCR::ABL1诱导的髓性白血病中发挥着关键作用.
- 针对TIF1β,结合现有疗法,可能为白血病提供一种新的治疗策略.
相关概念视频
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
General Transcription Factors
5.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K


